002A-00 woolly mammoth
Blog Archives
Dire Wolf De-Extinction: Inside Newsweek’s Look at Colossal’s Genetic Breakthrough
In this Newsweek feature, Colossal Biosciences shares how its team used ancient DNA and gene editing to create three pups—Romulus, […]
How Colossal’s Woolly Mouse Is Proving the Science Behind Mammoth Revival
In this OK! Magazine feature, the spotlight turns to Colossal Biosciences’ woolly mouse, a genetically engineered rodent with traits borrowed […]
Woolly Mouse Buzz: How Colossal’s Viral Rodent Captivated Celebrities
In this Newsweek feature, the focus is on Colossal Biosciences’ woolly mouse—engineered with golden fur and cold-adapted traits inspired by […]
Engineering the Woolly Mouse: How Colossal Validated Mammoth Traits in a Small Model
In this USA Today feature, Colossal Biosciences showcases its latest achievement: the woolly mouse. By targeting seven genes linked to […]
How Colossal’s Woolly Mouse Could Pave the Way for Mammoth Revival
In this People exclusive, Colossal Biosciences unveils the “woolly mouse” — engineered to express traits like dense golden fur and […]
CRISPR Breakthrough: Colossal’s Woolly Mouse Could Pave the Way for Mammoth Revival
Colossal Biosciences has revealed the “woolly mouse,” a genetically engineered rodent designed to replicate cold-adapted traits of the extinct woolly […]
The Colossal Steps Toward Engineering Immunity Against 2 of Australia’s Most Invasive Species
To combat Australia’s biodiversity crisis, the Colossal Foundation is equipping endangered species with resistance to some of their biggest threats. […]
How De-Extinction Could Protect Global Economies From Trillion-Dollar Losses
Colossal Biosciences positions de-extinction as more than a scientific milestone — it’s a potential safeguard against global economic risk. The […]
$200M Raised to Combat Extinction
Dear Colossal Community, Today is another historic day for Colossal: we have officially reached “decacorn” status, which means our company […]
Colossal Secures $200M to Accelerate De-Extinction and Genomic Innovation
Colossal Biosciences has secured $200 million in Series C funding led by TWG Global, elevating the Texas-based company’s valuation to […]
